Follow
Pietro Scalfaro
Pietro Scalfaro
Paediatrician, Senior Executive & Personalized Medicine Consultant
Verified email at clinikids.ch
Title
Cited by
Cited by
Year
The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse, A Kaul, E De Clercq, B Rosenwirth, JM Dumont, P Scalfaro, ...
Hepatology 43 (4), 761-770, 2006
3432006
The cyclophilin inhibitor Debio‐025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus
R Flisiak, A Horban, P Gallay, M Bobardt, S Selvarajah, ...
Hepatology 47 (3), 817-826, 2008
2982008
The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment‐naïve hepatitis C patients
R Flisiak, SV Feinman, M Jablkowski, A Horban, W Kryczka, ...
Hepatology 49 (5), 1460-1468, 2009
2812009
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice
L Gomez, H Thibault, A Gharib, JM Dumont, G Vuagniaux, P Scalfaro, ...
American Journal of Physiology-Heart and Circulatory Physiology 293 (3 …, 2007
2662007
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent
RG Ptak, PA Gallay, D Jochmans, AP Halestrap, UT Ruegg, LA Pallansch, ...
Antimicrobial agents and chemotherapy 52 (4), 1302-1317, 2008
1452008
Evaluation of a cyclophilin inhibitor in hepatitis C virus–infected chimeric mice in vivo
K Inoue, T Umehara, UT Ruegg, F Yasui, T Watanabe, H Yasuda, ...
Hepatology 45 (4), 921-928, 2007
1402007
Prevalence of nosocomial infections in Swiss children's hospitals
K Mühlemann, C Franzini, C Aebi, C Berger, D Nadal, J Stähelin, ...
Infection Control & Hospital Epidemiology 25 (9), 765-771, 2004
1012004
Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells
U Chatterji, MD Bobardt, R Stanfield, RG Ptak, LA Pallansch, PA Ward, ...
Journal of Biological Chemistry 280 (48), 40293-40300, 2005
892005
Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children
P Scalfaro, PD Sly, C Sims, W Habre
Anesthesia & Analgesia 93 (4), 898-902, 2001
832001
Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment
P Scalfaro, JJ Chesaux, PA Buchwalder, J Biollaz, JL Micheli
Intensive care medicine 24, 247-250, 1998
741998
Reliable tidal volume estimates at the airway opening with an infant monitor during high-frequency oscillatory ventilation
P Scalfaro, JJ Pillow, PD Sly, J Cotting
Critical care medicine 29 (10), 1925-1930, 2001
722001
Respiratory mechanics during sevoflurane anesthesia in children with and without asthma
W Habre, P Scalfaro, C Sims, K Tiller, PD Sly
Anesthesia & Analgesia 89 (5), 1177-1181, 1999
721999
Mechanical ventilatory support in infants with respiratory syncytial virus infection
F Leclerc, P Scalfaro, O Noizet, C Thumerelle, A Dorkenoo, C Fourier
Pediatric Critical Care Medicine 2 (3), 197-204, 2001
622001
The cyclophilin inhibitor DEBIO-025 has a potent dual anti-HIV and anti-HCV activity in treatment-naïve HIV/HCV co-infected subjects
R Flisiak, A Horban, J Kierkus, J Stanczak, I Cielnak, GP Stanczak, ...
Hepatology 44 (Suppl 1), 609A, 2006
382006
Feasibility of non-invasive pressure support ventilation in infants with respiratory failure after extubation: a pilot study
P Stucki, MH Perez, P Scalfaro, Q de Halleux, F Vermeulen, J Cotting
Intensive care medicine 35 (9), 1623-1627, 2009
372009
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients …
R Flisiak, SV Feinman, M Jablkowski, A Horban, W Kryczka, W Halota, ...
Journal of Hepatology 48, S62-S62, 2008
312008
Successful management of severe respiratory failure combining heliox with noninvasive high-frequency percussive ventilation
P Stucki, P Scalfaro, Q de Halleux, F Vermeulen, I Rappaz, J Cotting
Critical care medicine 30 (3), 692-694, 2002
212002
Farnesoid X receptor agonist for the treatment of chronic hepatitis B: a safety study
R Erken, P Andre, E Roy, N Kootstra, N Barzic, H Girma, C Laveille, ...
Journal of viral hepatitis 28 (12), 1690-1698, 2021
202021
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH
V Ratziu, SA Harrison, V Loustaud-Ratti, C Bureau, E Lawitz, ...
Journal of Hepatology 78 (3), 479-492, 2023
192023
Measuring end-expiratory lung volume and pulmonary mechanics to detect early lung function impairment in rabbits
W Habre, P Scalfaro, N Schütz, P Stucki, F Peták
Respiratory physiology & neurobiology 152 (1), 72-82, 2006
192006
The system can't perform the operation now. Try again later.
Articles 1–20